CClinicalTrials.gg
CompletedNCT02866409Updated Aug 15, 2016

Scalp Block Versus Scalp Infiltration With Dexmedetomidine and Local Anesthetic for Post Craniotomy Pain

A Phase 2 interventional study of scalp block and infiltration in Headache, sponsored by NAVNEH SAMAGH. Completed. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-08-15.

Sponsored by NAVNEH SAMAGH · Phase 2, Interventional, and Prevention

Phase
Phase 2
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study has been designed to assess the efficacy of dexmedetomidine as an adjuvant to local anaesthetic agent bupivacaine in scalp nerve block and scalp infiltration to control post craniotomy pain.A third group where patients were administered bupivacaine only infiltration has also been created.

Read the detailed description

Patients were randomly allocated into three equal groups by computer generated random numbers. For randomization, the simple random allocation rule was followed, wherein the total sample size (n = 150) was randomly divided into three equal groups. In the event of any case has to be excluded because of requirement of postoperative ventilation, altered sensorium or high grade fever in the post-operative period, the same random number code was allocated to the next patient in order to ensure an equal sample size without any modification to the original random number table. The random numbers were then kept in opaque sealed envelopes, numbered sequentially which were opened just before shifting patient inside operation theatre.

The anaesthesiologist who prepared and administered the study drug were not involved in collection of data. The anaesthesiologist who collected the data from the patient in the postoperative period, the operating surgeon and the patient were blinded to the group assigned to the patient.

Pre-operative Assessment:

Pre-operative anaesthetic evaluation was done on the day prior to the surgery. This included a detailed history regarding physical health, any co-morbid illness, current medications, drug allergy and previous anaesthetic experience. The patient was made familiar about the NRS (0-10, with 0 = no pain, 10 = worst pain ever). A written and informed consent was taken. Patients were fasted and premedicated according to the departmental protocol.

Duration of study period-

Study period started after closure of skin incision of the scalp and continued till 48 hours in the postoperative period

Study groups-

Patients were randomly divided into three groups:

Group BI - Bupivacaine infiltration around surgical incision.

Group BDI - Bupivacaine and dexmedetomidine infiltration around surgical incision

Group BDNB- Bupivacaine and dexmedetomidine used in scalp nerve block.

Anaesthesia Technique-

A standard anaesthesia technique according to the departmental protocol was followed in all the patients. Pre-induction monitoring (Datex- Ohmeda S/5 Avance, Madison, WI, USA) consisted of 5-lead electrocardiography, heart rate, automated non-invasive blood pressure, and pulse oximetry. The patients were then be induced with propofol (1-2 mg/kg) or thiopentone (4-6mg/kg) and trachea were intubated with vecuronium 0.1 mg/kg. Anaesthesia was maintained with intravenous (propofol) or inhalational (isoflurane/sevoflurane/desflurane) anaesthetic agent along with nitrous oxide-oxygen mixture (60:40) and intermittent doses of intravenous vecuronium (0.02 mg/kg). Ventilation was maintained at ETCO2 30 to 35mm Hg. Total fresh gas flow rate was kept at 1-2 L/min. A radial artery catheter was inserted for continuous blood pressure monitoring and blood sampling if indicated. Intraoperative analgesia was maintained with intravenous morphine 0.1mg/kg and morphine repeated at a dose of 0.05 mg/kg if duration of surgery was more than 3 hours. Patients were reversed with neostigmine (0.05mg/kg) and glycopyrolate (0.01mg/kg) after administration of study drugs and were extubated once patient started responding to verbal commands and able to generate adequate tidal volume under spontaneous respiration.

Methods of postoperative analgesia- In all the patients, analgesic procedure was done ensuring proper aseptic precaution at the end of the surgery, after closure of skin incision and before putting the dressings over the incision. Patients were reversed from anaesthesia after the administration of study drugs.

Group BI: The incision site was infiltrated with 15-20 ml of bupivacaine (0.25%). {1/3rd in the muscle and 2/3rd in the subcutaneous tissue}. Maximum dose of bupivacaine kept less than 2 mg /kg.

Group BDI: The incision site was infiltrated with 15-20 ml bupivacaine (0.25%) and dexmedetomedine (1 µg/kg). {1/3rd in the muscle and 2/3rd in the subcutaneous tissue}. Maximum dose of bupivacaine kept less than 2 mg /kg.

Group BDNB: Scalp nerve blocks were given with15-20 ml of combination of Bupivacaine (0.25%) and Dexmedetomedine (1 µg/kg). Maximum dose of bupivacaine kept less than 2 mg /kg.

In this group following nerves were blocked-

  1. Supra-orbital nerve
  2. Supra-trochlear nerve
  3. Zygomatico-temporal nerve
  4. Auriculo-temporal nerve
  5. Posterior auricular branches of the greater auricular Nerve
  6. The greater, lesser, and third occipital nerves

Post-operative assessment:

After extubation patients were shifted to the Post anaesthesia care unit (PACU) and assessed for haemodynamic parameters, sedation and any complication at 15 minutes interval till 2hrs and then at 4, 8, 12, 16, 20, 24, 36 and 48 hours. Assessed for cognitive function at 30 min and 60 min.

Patients were followed after discharge for 6 months by telephonic communication at 1, and 3 month interval for presence of chronic pain.

COLLECTION OF DATA-

Preoperative- Age, sex, weight, ASA status, diagnosis, surgery

Intraoperative-

  1. Site of incision
  2. Duration of surgery
  3. Intra-operative analgesia- morphine in mg/kg

Postoperative-

  1. Haemodynamic parameters- Heart rate, systolic and diastolic blood pressure, oxygen saturation was recorded at arrival to PACU and every 15 min interval for 2 hours. Then heart rate and systolic and diastolic blood pressure at 4, 8, 12, 16, 20, 24, 36 and 48 hours after surgery.
  2. Respiration rate-was recorded at arrival to PACU and every 15 min interval for 2 hours and then at 4, 8, 12, 16, 20, 24, 36 and 48 hours after surgery.
  3. Cognitive function- Patients were evaluated for cognitive function 30 minutes after shifting to PACU using a modified self-devised questionnaire of short orientation memory concentration test.

    Whenever the subjects were able to recall and count with minimal mistakes (1 to 3), were regarded as good, with more than 3 mistakes as fair, and if not be able to recall at all, it was regarded as poor. If the cognitive function outcome was poor then same test was repeated at 1 hour after shifting to PACU. If outcome was again poor, then that patient was excluded from the study.

  4. Assessment of pain- Postoperative pain was assessed by Numerical rating scale (NRS) where in 0 shows 'no pain' and 10 shows 'worst imaginable excruciating pain'. It was assessed at arrival to PACU and at 0, 0.5, 1, 1.5, 2, 4, 8, 12, 16, 20, 24, 36 and 48 hours after surgery.
  5. Pain free period- Time of first rescue analgesic administration from the time of test drug administration was recorded.
  6. Postoperatively rescue analgesic- When NRS score was ≥ 4, rescue analgesic paracetamol 1gm was administered intravenously and total rescue analgesic requirement in 24 and 48 hrs were noted.
  7. Rescue drugs to maintain haemodynamic stability- Any adverse events like bradycardia (Heart rate ≤ 40), hypotension (SBP \< 90 mm of Hg) were recorded and treated by rescue drugs: atropine-15µg/Kg and mephenteramine-3mg/dose respectively. Total amount of rescue drug requirement in 24 and 48 hours were noted.
  8. Postoperative sedation- Level of sedation was assessed using Modified Ramsay Sedation Scale.
  9. Adverse events-

    1. Respiratory depressions (Respiration rate \< 8 breaths/min) was recorded and managed accordingly.
    2. Postoperative nausea and vomiting (PONV) was assessed on a 4-point scale. and was treated with ondansetron 0.15 mg/kg intravenously if score was >2.
02

Conditions studied

  • Headache

Browse trials for

Keywords

  • dexmedetomidine
  • nerve block
  • anesthesia infiltration
03

In context

Headache

1,226 studies on the registry are indexed under Headache; 202 are open to participants now.

This study's enrollment of 150 is above the median of 60 across 918 interventional studies indexed under Headache.

Browse Headache studies →

Lead sponsor

This is the only study on the registry with NAVNEH SAMAGH as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Neurosurgical patients
  • 18-70 years of age
  • ASA class I and II
  • Patients undergoing elective craniotomy, who were conscious and oriented to time, person and place and able to understand and use Numerical Rating Scale (NRS)

Exclusion criteria

Exclusion Criteria:

  • Patient dull and irritable
  • GCS \<15
  • Craniotomy incision extending beyond scalp (the field of the block) e.g. craniofacial surgery
  • Patients treated chronically with analgesics or narcotic medications
  • Allergy to local anaesthetics or dexmedetomedine
  • Patients planned for post-operative mechanical ventilation

Following patients were excluded from the study during collection of data in the postoperative period:-

  • Patients developing fever (≥39°C) in the postoperative period
  • Requiring postoperative ventilation (unplanned)
  • Having poor cognitive function at 1 hour postoperative period
  • GCS \<15 in post-operative period.
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    Bupivacaine,dexmedetomidine scalp block

    Bupivacaine (0.25%) and Dexmedetomedine (1 µg/kg). Maximum dose of bupivacaine kept \< 2 mg /kg for scalp block

    Procedure: scalp block · Drug: Dexmedetomidine · Drug: Bupivacaine

  • Active comparator
    bupivacaine dexmedetomidine infiltration

    The incision site was infiltrated with 15-20 ml bupivacaine (0.25%) and dexmedetomedine (1 µg/kg). {1/3rd in the muscle and 2/3rd in the subcutaneous tissue}. Maximum dose of bupivacaine kept less than 2 mg /kg.

    Procedure: infiltration · Drug: Dexmedetomidine · Drug: Bupivacaine

  • Active comparator
    bupivacaine infiltration

    The incision site was infiltrated with 15-20 ml of bupivacaine (0.25%). {1/3rd in the muscle and 2/3rd in the subcutaneous tissue}. Maximum dose of bupivacaine kept less than 2 mg /kg.

    Procedure: infiltration · Drug: Bupivacaine

Interventions

  • Procedurescalp block

    In this group following nerves were blocked- 1. Supra-orbital nerve 2. Supra-trochlear nerve 3. Zygomatico-temporal nerve 4. Auriculo-temporal nerve 5. Posterior auricular branches of the greater auricular Nerve 6. The greater, lesser, and third occipital nerves

  • Procedureinfiltration

    The incision site was infiltrated with drug. {1/3rd in the muscle and 2/3rd in the subcutaneous tissue}.

  • DrugDexmedetomidine

    Dexmedetomidine was administered as a dose of 1 µg/kg in 20 ml 0.25% bupivacaine for scalp block or infiltration.

    Also known as: Precedex, Dexdor

  • DrugBupivacaine

    20 ml of Bupivacaine 0.25% was administered to the patients either in the form of scalp block or infiltration

    Also known as: Marcaine, Sensorcaine, Marcain

06

What researchers measure

Primary outcomes

  1. post craniotomy pain by Numerical rating scale (NRS)

    Numerical rating scale (NRS) is a scale from 0 to 10 where 0 shows 'no pain' and 10 shows 'worst imaginable excruciating pain

    Time frame: Immediately after extubation

  2. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 30 minutes after extubation

  3. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 1 hour after extubation

  4. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 1.5 hours after extubation

  5. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 2 hours after extubation

  6. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 4 hours post extubation

  7. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 8 hours post extubation

  8. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 12 hours post extubation

  9. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 16 hours post extubation

  10. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 20 hours post extubation

  11. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 24 hours post extubation

  12. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 36 hours post extubation

  13. post craniotomy pain by Numerical rating scale (NRS)

    Time frame: 48 hours post extubation

Secondary outcomes

  1. chronic pain using Numerical rating scale (NRS)

    Numerical rating scale (NRS) is a scale from 0 to 10 where 0 shows 'no pain' and 10 shows 'worst imaginable excruciating pain

    Time frame: 1 month

  2. chronic pain using Numerical rating scale (NRS)

    Time frame: 3 months

  3. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 15 minutes interval till 2hrs post extubation and then at 4, 8, 12, 16, 20, 24, 36 and 48 hours.

  4. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 4 hours

  5. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 8 hours.

  6. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 12 hours.

  7. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 16 hours.

  8. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 20 hours.

  9. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 24 hours.

  10. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 36 hours.

  11. post operative sedation using Modified Ramsay Sedation Scale

    Sedation Score-- by Modified Ramsay Sedation Scale 1. Anxious/ Agitated/ Restless 2. Cooperative/ Oriented/ Tranquil 3. Responds to verbal commands 4. Brisk response to light glabellar tap or loud noise 5. Sluggish response to light glabellar tap or loud noise 6. No Response

    Time frame: 48 hours.

  12. rescue analgesic requirement in grams

    total rescue analgesic requirement in grams of paracetamol consumed in 24 hours

    Time frame: 24 hrs

  13. rescue analgesic requirement in grams

    total rescue analgesic requirement in grams of paracetamol consumed in 48 hours

    Time frame: 48 hrs

Other outcomes

  1. heart rate in beats per minute(bpm)

    15 minutes interval till 2hrs post extubation

    Time frame: 15 minutes interval till 2hrs

  2. heart rate in beats per minute(bpm)

    Time frame: 4 hours.

  3. heart rate in beats per minute(bpm)

    Time frame: 8 hours.

  4. heart rate in beats per minute(bpm)

    Time frame: 12 hours.

  5. heart rate in beats per minute(bpm)

    Time frame: 16 hours.

  6. heart rate in beats per minute(bpm)

    Time frame: 20 hours.

  7. heart rate in beats per minute(bpm)

    Time frame: 24 hours.

  8. heart rate in beats per minute(bpm)

    Time frame: 36 hours.

  9. heart rate in beats per minute(bpm)

    Time frame: 48 hours.

  10. systolic blood pressure in mm of Hg

    15 minutes interval till 2hrs post extubation

    Time frame: 15 minutes interval till 2hrs

  11. systolic blood pressure in mm of Hg

    Time frame: 4 hours.

  12. systolic blood pressure in mm of Hg

    Time frame: 8 hours.

  13. systolic blood pressure in mm of Hg

    Time frame: 12 hours.

  14. systolic blood pressure in mm of Hg

    Time frame: 16 hours.

  15. systolic blood pressure in mm of Hg

    Time frame: 20 hours.

  16. systolic blood pressure in mm of Hg

    Time frame: 24 hours.

  17. systolic blood pressure in mm of Hg

    Time frame: 36 hours.

  18. systolic blood pressure in mm of Hg

    Time frame: 48 hours.

  19. Diastolic blood pressure in mm of Hg

    15 minutes interval till 2hrs post extubation

    Time frame: 15 minutes interval till 2hrs

  20. Diastolic blood pressure in mm of Hg

    Time frame: 4 hours.

  21. Diastolic blood pressure in mm of Hg

    Time frame: 8 hours.

  22. Diastolic blood pressure in mm of Hg

    Time frame: 12 hours.

  23. Diastolic blood pressure in mm of Hg

    Time frame: 16 hours.

  24. Diastolic blood pressure in mm of Hg

    Time frame: 20 hours.

  25. Diastolic blood pressure in mm of Hg

    Time frame: 24 hours.

  26. Diastolic blood pressure in mm of Hg

    Time frame: 36 hours.

  27. Diastolic blood pressure in mm of Hg

    Time frame: 48 hours.

  28. SpO2 in percentage

    Time frame: 15 minutes interval till 2hours.

  29. SpO2 in percentage

    Time frame: 4 hours.

  30. SpO2 in percentage

    Time frame: 8 hours.

  31. SpO2 in percentage

    Time frame: 12 hours.

  32. SpO2 in percentage

    Time frame: 16 hours.

  33. SpO2 in percentage

    Time frame: 20 hours.

  34. SpO2 in percentage

    Time frame: 24 hours.

  35. SpO2 in percentage

    Time frame: 36 hours.

  36. SpO2 in percentage

    Time frame: 48 hours.

  37. respiratory rate in breaths per minute

    respiratory rate in breaths per minute at 15 minutes interval till 2hrs in post operative period after extubation

    Time frame: 15 minutes interval till 2hrs

  38. respiratory rate in breaths per minute

    Time frame: 4 hours.

  39. Respiratory rate in breaths per minute

    Time frame: 8 hours.

  40. Respiratory rate in breaths per minute

    Time frame: 12 hours.

  41. Respiratory rate in breaths per minute

    Time frame: 16 hours.

  42. Respiratory rate in breaths per minute

    Time frame: 20 hours.

  43. Respiratory rate in breaths per minute

    Time frame: 24 hours.

  44. Respiratory rate in breaths per minute

    Time frame: 36 hours.

  45. Respiratory rate in breaths per minute

    Time frame: 48 hours.

  46. cognitive function using Modified self-devised questionnaire of short orientation memory concentration

    Modified self-devised questionnaire of short orientation memory concentration test 1. What date is it today? 2. What is the current year? 3. What is his/her birthday? 4. Count numbers 1 to 10. 5. Count reverse numbers from 10 to 1.

    Time frame: 30 minutes

  47. cognitive function using Modified self-devised questionnaire of short orientation memory concentration

    Modified self-devised questionnaire of short orientation memory concentration test 1. What date is it today? 2. What is the current year? 3. What is his/her birthday? 4. Count numbers 1 to 10. 5. Count reverse numbers from 10 to 1.

    Time frame: 60 minutes

  48. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 15 minutes interval till 2hrs

  49. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 4 hours.

  50. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 8 hours.

  51. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 12 hours.

  52. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 16 hours.

  53. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 20 hours.

  54. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 24 hours.

  55. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 36 hours.

  56. post operative nausea vomiting using Postoperative Nausea and Vomiting Scale

    Postoperative Nausea and Vomiting Scale 1. No PONV: Absence of any emesis or nausea. 2. Mild PONV: Patient having only mild nausea / one emetic episode / nausea lasting for less than 10 minutes and where no antiemetic is required. 3. Moderate PONV: Patient has 1-2 emetic episodes / moderate to severe nausea and antiemetic therapy is required. 4. Severe PONV: Patient has more than 2 emetic episodes / is nauseated more than twice \& more than one antiemetic required.

    Time frame: 48 hours.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02866409
Lead sponsor
NAVNEH SAMAGH
Collaborators
Post Graduate Institute of Medical Education and Research, Chandigarh
Responsible party
NAVNEH SAMAGH (senior resident, Post Graduate Institute of Medical Education and Research, Chandigarh) — Sponsor-investigator
First posted
Aug 15, 2016
Start date
Nov 2013
Primary completion
Dec 2014
Completion
Jan 2015
Last update
Aug 15, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion